Skip to content

Clinical study of Kinesio taping on hand dysfunction intervention after stroke

Kinesio taping on hand dysfunction intervention after stroke: a randomized, single-blind and placebo-controlled clinical study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036230
Enrollment
Unknown
Registered
2020-08-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

experimental group:Kinesio taping + conventional rehabilitation therapy
control group:placebo taping + conventional rehabilitation therapy

Sponsors

Shanghai First People's Hospital /Shanghai General Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: According to the diagnostic criteria of various types of cerebrovascular disease approved by the 4th Cerebrovascular Disease Academic Conference, the newly diagnosed patients with cerebral infarction or cerebral hemorrhage will have hemiplegia as initial symptom on involved side and confirmed by CT or MRI. And meet the following conditions: 1. Stable vital signs; 2. 45 years old < age < 65 years (inclusive); one side (with at least one side upper extremity) dysfunction; 3. the course of disease does not exceed 6 months (at least 3 days after cerebral infarction patients are stable, at least 1 week after cerebral hemorrhage patients are stable); 4. Brunnstrom: II-IV stage; 5. Ashworth Scale: less than Grade 3.

Exclusion criteria

Exclusion criteria: 1. Recent indications for thrombolysis or thrombolysis, or one of the following: a history of conscious, mental, and intellectual disabilities (including history of dementia, deafness, and dumbness); 2. Combined with severe skeleton and joint disease, joint contracture and/ or rigidity, combined with agnosia and apraxia of the affected side extremity, combined with Parkinson's syndrome, epilepsy, water and electrolyte disorders, equipped with a pacemaker, severe malnutrition, severe cardiopulmonary disease, respiratory failure, active liver disease, liver and kidney insufficiency, congestive heart failure, malignant progressive hypertension; 3. Those who do not cooperate with treatment and cannot be followed up in the field.

Design outcomes

Primary

MeasureTime frame
surface Electromyograph, sEMG;

Secondary

MeasureTime frame
manual muscle test, MMT;modified Ashworth scale, MAS;Wolf motor function test, WMFT;FugI-Meyer assessment of upper extremity, FMA-UE;modified Barthel index, MBI;satisfaction with life scale, SWLS;

Countries

China

Contacts

Public ContactBo Yu

Shanghai First People's Hospital /Shanghai General Hospital, Shanghai Jiaotong University

yubo@vip.163.com+86 13901807928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026